[Treatment of patients with chronic liver diseases with a hepatotrophic preparation].
D001663:Bilirubin / Q000097:blood; D002802:Cholinesterases / Q000097:blood; D002908:Chronic Disease; D005492:Folic Acid / Q000627:therapeutic use*; D006505:Hepatitis / Q000188:drug therapy*; D006801:Humans; D008103:Liver Cirrhosis / Q000188:drug therapy*; D008715:Methionine / Q000627:therapeutic use*; D009536:Niacinamide / Q000627:therapeutic use*; D009705:Nucleosides / Q000627:therapeutic use*; D012256:Riboflavin / Q000627:therapeutic use*; D012709:Serum Albumin / Q000032:analysis; D014805:Vitamin B 12 / Q000627:therapeutic use*; D005719:gamma-Globulins / Q000032:analysis
D009705:Nucleosides; D012709:Serum Albumin; D005719:gamma-Globulins; D009536:Niacinamide; D005492:Folic Acid; D008715:Methionine; D002802:Cholinesterases; D014805:Vitamin B 12; D001663:Bilirubin; D012256:Riboflavin
Su un saggio di trattamento di epatopazienti cronici con un preparato epatotropo.